MOUNTAIN VIEW, Calif., Oct. 5 /PRNewswire-FirstCall/ — Omnicell, Inc., (Nasdaq:
OMCL) a leading provider of medication management solutions to
acute healthcare facilities, today announced the acquisition of Pandora Data Systems,
a leading provider of analytical software for medication diversion
detection and regulatory compliance. The two companies will combine
their expertise in medication analytics to enhance diversion
detection and clinical benchmarking that helps to ensure regulatory
compliance.
“We believe the two companies’ complementary, best-in-class
products and technologies will be of great value to all of our
customers,” said Jim Felich, CEO of Pandora Data Systems. “Our
partnership with the Omnicell team will allow us to continue our
commitment to patient safety and help hospital systems meet the
increasingly stringent requirements of the DEA and The Joint
Commission.”
The Pandora Data Systems solution will continue to operate as a
stand-alone product, producing reports for CareFusion, McKesson,
Cerner and other medication management systems, and providing
regular updates and releases for its customer base.
Pandora will leverage the Omnicell development expertise to
provide best-in-class analytics for drug diversion detection,
compliance reporting and long term data storage. Its
customers will also benefit from Omnicell’s infrastructure for
expanded service and support.
“I am thrilled to welcome the Pandora employees and customers to
the Omnicell family, as together, we commit to the universal
improvement of healthcare,” said Randall Lipps, CEO of Omn
‘/>”/>
SOURCE
